USPTO serial 79214005
ONCOSNIPE
Reviewed by CopyMark Law Group
Reg. 5516066Status 709
- Filing date
- Status date
- Registration date
- Jul 17, 2018
- Examiner
- MESSICK, TABITHA LEE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ONCOSNIPE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
ONCODESIGN, Société Anonyme à Conseil d'Administration
F-21000 DIJON, FR
Other trademarks owned by ONCODESIGN, Société Anonyme à Conseil d'Administration
ONCODESIGN, Société Anonyme à Conseil d'Administration
F-21000 DIJON, FR
Other trademarks owned by ONCODESIGN, Société Anonyme à Conseil d'Administration
ONCODESIGN, Société Anonyme à Conseil d'Administration
F-21000 DIJON, FR
Other trademarks owned by ONCODESIGN, Société Anonyme à Conseil d'Administration
FR
ONCODESIGN PRECISION MEDICINE (OPM)
FR
Other trademarks owned by ONCODESIGN PRECISION MEDICINE (OPM)
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michelle P. Ciotola
Michelle P. Ciotola Cantor Colburn LLP20 Church Street22nd FloorHartford, CT 06103Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software for use in patient stratification, identification of patients resistant to cancer treatments, identification of therapeutic targets, and identification of biomarkers; downloadable software for use in cancer diagnostic, for use with cancer treatment | SECTION 71 - CANCELLED | — |
| 042 | Scientific research; software as a service (SaaS) featuring software use in patient stratification, identification of patients having resistance to cancer treatment, identification of therapeutic targets, and identification of biomarkers; computer software development; technical project studies, namely, conducting feasibility studies, technical research in the field of cancer research and in the field of identification of patients having resistance to anticancer treatment | SECTION 71 - CANCELLED | — |
| 044 | Medical analysis for providing cancer treatment, and providing medical services in the nature of medical identification of patients resistance to treatments; medical care and identification and analysis services in the nature of medical diagnosis of cancer, all relating to patient treatment | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ONCODESIGN, Société Anonyme à Conseil d'Administration
- Other trademarks owned by ONCODESIGN, Société Anonyme à Conseil d'Administration
- Other trademarks owned by ONCODESIGN, Société Anonyme à Conseil d'Administration
- Other trademarks owned by ONCODESIGN SERVICES
- Other trademarks owned by ONCODESIGN PRECISION MEDICINE (OPM)
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ONCOSNIPE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 9, 2026 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 22, 2026 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Mar 22, 2026 | INPC | INVALIDATION PROCESSED | — |
| Sep 30, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 31, 2025 | C71T | CANCELLED SECTION 71 | — |
| Aug 16, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 16, 2024 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Mar 16, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 17, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 21, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 30, 2018 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Oct 30, 2018 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Oct 17, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 17, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 1, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 1, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 27, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 11, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 11, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 11, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 28, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 28, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 28, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 28, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 28, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 9, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 9, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 6, 2018 | ALIE | ASSIGNED TO LIE | — |
| Feb 22, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 21, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 21, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 9, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 23, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 23, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 20, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 19, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 19, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 15, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 15, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 10, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |